Skip to main content
Equibles
LFMD logo

LFMD · LifeMD, Inc. · Metrics

Track LFMD — free

Use LFMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LFMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.17 +0.03 (+1.40%) At close · Oct 22
Russell 2000 member Rebalance outlook locked
Market Cap
$104.60M
Shares
48.20M
Volume · Oct 22 674.29K Avg daily vol (3M) 855.07K

LFMD metrics

83 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.17
Market cap
$104.60M

Price action

20 metrics
Price change (1W)
-11.8%
Price change (30D)
-34.2%
Price change (3M)
-43.9%
Price change (6M)
-52.2%
Price change (YTD)
-36.4%
Price change (1Y)
-64.7%
Trailing year
Price change (5Y)
-56.5%
52-week high
$6.30
52-week low
$2.14
Change from 52-week high
-65.6%
Change from 52-week low
+1.4%
Annualized volatility
79.8%
Annualized volatility (3M)
58.5%
Beta
2.0
RSI (14D)
25.0
Price vs SMA 50
-26.6%
Price vs SMA 200
-41.6%
Avg volume (3M)
855,059
Relative volume
0.8
Average dollar volume
$2.72M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
48.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 245.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 185.7%
P / book
12.9
reciprocal yield 7.7%
FCF yield
-10.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.4×
reciprocal yield 70.0%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 73.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
3.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
87.5%
Operating margin
-10.5%
Trailing 12 months
Net margin
-0.2%
Gross profit (TTM)
$167.64M
Operating profit (TTM)
−$20.20M
Net income (TTM)
−$330,834
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-5.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$4.08
Gross profit per diluted share (TTM)
$3.57
Operating profit per diluted share (TTM)
$-0.43
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$0.00
Operating cash flow per diluted share (TTM)
$-0.21
Free cash flow per diluted share (TTM)
$-0.23
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.17
Book value per share
$0.50

Growth

11 metrics
Revenue growth YoY
-3.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$191.59M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+7.6%
Year over year · more shares
Revenue CAGR (3Y)
+17.7%
Revenue CAGR (5Y)
+39.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-4.2%
Return on assets
-0.6%
Debt / equity
0.0
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
−$11.06M
Quick ratio
0.8
Interest coverage
-150.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$25.14M
Latest balance sheet
Cash & equivalents
$25.14M
Total assets
$59.89M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$9.91M
Capital expenditures (TTM)
$1.15M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$8.09M
R&D / revenue
—
Stock compensation / revenue
4.2%

Ownership (13F)

9 metrics
13F filers
117
13F filer change QoQ
+14
Institutional ownership
47.7%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
13.5%
Private-fund adviser ownership
12.7%
Active holders' share change QoQ
+37.8%
Holder tenure
8.8
Price vs estimated holder cost
-35.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.6%

Short interest

3 metrics
Short interest
15.7%
Latest settlement · 10.4 days to cover
Days to cover
10.4d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 948320 CUSIP 53216B104 13F (30d) 14 filings 14 filers Visit website Investor relations